Generate a tailored SOP for Dr. Mina Tadrous. Improve your application with a focused, well-structured draft.
Mina Tadrous leads research focused on evaluating drug policies and post-marketing surveillance of medications. She works closely with policymakers and utilizes large data sets to answer questions regarding medication real-world safety and effectiveness, aiming to improve the optimal use of medications. Tadrous is currently a scientist at Women’s College Hospital (WCH) and an investigator with Ontario Drug Policy Research Network (ODPRN), as well as an adjunct scientist at ICES. She holds a Tier 2 Canada Research Chair in Real World Evidence and Pharmaceutical Policy. Her work is a critical cornerstone of the health care system, as she aims to optimize effectiveness while minimizing risks associated with medications. Tadrous focuses on leveraging big data to help health care practitioners make evidence-based decisions. For instance, she analyzes data from government-funded medical care in Ontario to track health care usage and provide insights into the real-world safety and effectiveness of specific medications. Her partnerships with policymakers have led to significant policy changes that improve access to essential medications for patients.
Leslie Dan Faculty of Pharmacy • Toronto, Canada
Teaches and conducts research in drug safety and pharmaceutical policy.
Department of Sociology